Absci Corporation ABSI Enterprise value

Enterprise value at other companies

SchrodingerSDGR

$1.03B-26.2%

Recursion Pharmaceuticals, Inc.RXRX

$1.47B-13.4%

Spyre Therapeutics, Inc.SYRE

-$189.23M-1,369%

AbCellera Biologics Inc.ABCL

$2.39B+113%

AnaptysBio, Inc.ANAB

$1.35B+176%

Assembly BiosciencesASMB

$411.56M+702%

FAQ

What is Absci Corporation's enterprise value?

Absci Corporation (ABSI) reported enterprise value of $453.38M in Q1 2026.

How has Absci Corporation's enterprise value changed year-over-year?

Absci Corporation's enterprise value increased by 73.1% year-over-year, from $261.86M to $453.38M.

What is the long-term trend for Absci Corporation's enterprise value?

Over 4 years (2021 to 2025), Absci Corporation's enterprise value has grown at a 0.4% compound annual growth rate (CAGR), from $499.72M to $508.15M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.